CD58 expression does not impact response to inotuzumab ozogamicin in patients with B‐cell acute lymphoblastic leukemia

Documenti analoghi

• Outcomes for Patients With Myeloid Neoplasms Treated With Chemotherapy Plus Venetoclax After Prior Venetoclax Therapy
  di: Rafael Madero‐Marroquin, et al.
  Pubblicazione: (2025)
• B‐lymphoblastic leukemia/lymphoma with DUX4 rearrangement
  di: Wing Kit Lam, et al.
  Pubblicazione: (2024)
• CD117 expression predicted FLT3 mutation in T‐cell acute lymphoblastic leukemia
  di: Haijin Wang, et al.
  Pubblicazione: (2024)
• Bone marrow‐restricted aberrant myeloperoxidase expression in B‐acute lymphoblastic leukemia: A diagnostic dilemma and mimicry of mixed phenotype acute leukemia
  di: Wei J. Wang, et al.
  Pubblicazione: (2024)
• Clinical significance of Philadelphia‐like‐related genes in a resource‐constrained setting of adult B‐acute lymphoblastic leukemia patients
  di: Keli Lima, et al.
  Pubblicazione: (2024)